- £4.43bn
- £1.36bn
- £2.12bn
- 25
- 88
- 99
- 84
R2019 March 31st | R2020 March 31st | 2021 March 31st | 2022 March 31st | R2023 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | Interim Report |
Standards: | IFRS | IFRS | IFRS | IFRS | — |
Status: | Final | Final | Final | Final | Final |
Interest Income | |||||
Interest Expense | |||||
Net Interest Income | 817 | 839 | 778 | 945 | 1,294 |
Loan Loss Provision | |||||
Net Interest Income After Loan Loss Provision | 750 | 705 | 679 | 916 | 1,213 |
Non Interest Income | |||||
Non Interest Expense | |||||
Net Income Before Taxes | 515 | 310 | 332 | 697 | 894 |
Provision for Income Taxes | |||||
Net Income After Taxes | 484 | 277 | 259 | 556 | 746 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 534 | 1,135 | 268 | 516 | 805 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | 490 | 1,091 | 234 | 477 | 764 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.472 | 0.305 | 0.25 | 0.505 | 0.761 |
Dividends per Share |